Newsroom

News

Dr. Mathieu Simon and Catherine Combot-Plétan join the Board of Directors of biotech firm LNC...

Dec 11, 2018

more +
Press / Medias

A Bordeaux, LNC Therapeutics veut développer l’arme absolue contre l’obésité

Oct 26, 2018

more +
Press / Medias

LNC Therapeutics Acquires Exclusive License for the Christensenella Patent from Cornell University

Oct 17, 2018

more +
News

LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University

Oct 15, 2018

more +
Press / Medias

LNC Therapeutics lance son nouvel essai clinique, OBEMINALE 2, et traite son premier patient

Oct 10, 2018

more +
News

LNC Therapeutics launches a new clinical trial, OBEMINALE 2, and treats its first patient

Oct 2, 2018

more +

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions